Hypoxia treatment reverses neurodegenerative disease in a mouse model of Leigh syndrome.
about
Loss of Mitochondrial Ndufs4 in Striatal Medium Spiny Neurons Mediates Progressive Motor Impairment in a Mouse Model of Leigh Syndrome.Therapeutic effects of the mitochondrial ROS-redox modulator KH176 in a mammalian model of Leigh Disease.Low-dose rapamycin extends lifespan in a mouse model of mtDNA depletion syndrome.Metabolic etiologies in West syndrome.Towards a therapy for mitochondrial disease: an update
P2860
Hypoxia treatment reverses neurodegenerative disease in a mouse model of Leigh syndrome.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Hypoxia treatment reverses neurodegenerative disease in a mouse model of Leigh syndrome.
@ast
Hypoxia treatment reverses neurodegenerative disease in a mouse model of Leigh syndrome.
@en
type
label
Hypoxia treatment reverses neurodegenerative disease in a mouse model of Leigh syndrome.
@ast
Hypoxia treatment reverses neurodegenerative disease in a mouse model of Leigh syndrome.
@en
prefLabel
Hypoxia treatment reverses neurodegenerative disease in a mouse model of Leigh syndrome.
@ast
Hypoxia treatment reverses neurodegenerative disease in a mouse model of Leigh syndrome.
@en
P2093
P2860
P50
P356
P1476
Hypoxia treatment reverses neurodegenerative disease in a mouse model of Leigh syndrome
@en
P2093
David E Sosnovik
Emanuele Rezoagli
Marielle Scherrer-Crosbie
Olga Goldberger
Robrecht Thoonen
Vamsi K Mootha
Warren M Zapol
P2860
P304
E4241-E4250
P356
10.1073/PNAS.1621511114
P407
P577
2017-05-08T00:00:00Z